[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"head-pain\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:head-pain":30},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,2,0,[8,50],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":16,"sex":17,"minAge":18,"maxAge":19,"enrollmentInfo":20,"targetDuration":4,"studyType":23,"phases":24,"briefSummary":26,"conditions":27,"keywords":31,"overallStatus":37,"whyStopped":4,"lastUpdateSubmitDate":38,"lastUpdatePostDateStruct":39,"startDateStruct":42,"completionDateStruct":44,"leadSponsor":46,"locationsCount":49},"100604868","different-intraperitoneal-pressures-on-optic-nerve-sheath-diameter-in-laparoscopic-surgeries-100604868",false,"NCT07155109","Different Intraperitoneal Pressures on Optic Nerve Sheath Diameter in Laparoscopic Surgeries","The Effects of Different Intraperitoneal Pressures on Optic Nerve Sheath Diameter in Laparoscopic Gyneco-oncologic Surgeries","Inclusion Criteria:\n\n* Laparoscopic gyneco-oncological surgeries\n* Female patients aged 18-65 years\n* ASA physical status classification I-II-III patients\n\nExclusion Criteria:\n\n* Patients with diabetic retinopathy\n* Patients with glaucoma\n* Patients with cerebrovascular disease\n* Pregnant women\n* Patients with known allergy to anaesthetic agents\n* Morbidly obese patients with BMI \\> 40",true,"FEMALE","18 Years","65 Years",{"count":21,"type":22},100,"ESTIMATED","INTERVENTIONAL",[25],"NA","The aim of this study is to investigate the effects of low and normal intraperitoneal pressures on intraoperative optic nerve sheath diameter in laparoscopic gyneco-oncologic surgeries.",[28,29,30],"Intracranial Pressure Increase","Abdominal Pain","Head Pain",[32,33,34,35,36],"Intracranial Pressure","optic nerve","laparascopy","gyneco-oncologic surgery","low pressure","NOT_YET_RECRUITING","2025-08-27",{"date":40,"type":41},"2025-09-04","ACTUAL",{"date":43,"type":22},"2025-08-30",{"date":45,"type":22},"2025-10-20",{"name":47,"class":48},"Diskapi Yildirim Beyazit Education and Research Hospital","OTHER_GOV",1,{"id":51,"slug":52,"hasResults":11,"nctId":53,"briefTitle":54,"officialTitle":55,"acronym":4,"eligibilityCriteria":56,"healthyVolunteers":11,"sex":57,"minAge":18,"maxAge":58,"enrollmentInfo":59,"targetDuration":4,"studyType":23,"phases":61,"briefSummary":54,"conditions":63,"keywords":64,"overallStatus":70,"whyStopped":4,"lastUpdateSubmitDate":71,"lastUpdatePostDateStruct":72,"startDateStruct":74,"completionDateStruct":76,"leadSponsor":78,"locationsCount":49},"100464275","phase-3-intravenous-magnesium-sulfate-vs-placebo-to-treat-non--traumatic-acute-headaches-in-the-emergency-department-100464275","NCT05325580","Intravenous Magnesium Sulfate Vs Placebo to Treat Non -Traumatic Acute Headaches in the Emergency Department","Intravenous Magnesium Sulfate Vs Placebo to Treat Non-traumatic Acute Headaches in the Emergency Department","Inclusion Criteria:\n\n* informed consent\n* age \\>18 years\n* Acute non-traumatic acute headaches\n* patients treated in ED\n* Magnesium sulfate and aspirin administered intravenously (IV)\n\nExclusion Criteria:\n\n* Current regular use of analgesics, anticonvulsants or antidepressants\n* Renal disorder with a low glomerular filtration rate (\\\u003C60 ml\u002Fmin)\n* Neuromuscular disorder\n* Pregnant woman\n* Contrindication\n* Allergy to NSAID\n* Traumatic Headache\n* Chronic headache ( headache occurring at least 15 days per month for at least 3 months)\n* Hemodynamic instability","ALL","85 Years",{"count":60,"type":22},424,[62],"PHASE3",[30],[65,66,67,68,69],"intavenous","magnesium sulfate","nontraumatic","acute headaches","placebo","RECRUITING","2024-02-27",{"date":73,"type":41},"2024-02-28",{"date":75,"type":41},"2021-12-01",{"date":77,"type":22},"2026-12-30",{"name":79,"class":80},"University of Monastir","OTHER"]